InsidersTradesSigma
Discover the detailed record of transactions filed by Mansbach Harry H, Directeur Médical. Insider active across 1 companies, notably 89bio, Inc.. In total, 2 reports have been published. The latest transaction was disclosed on 5 February 2022 — Retenue fiscale. Regulator: SEC (Form 4). The full history is free.
2 of 2 declarations
Harry H. Mansbach is the Chief Medical Officer at 89bio, Inc. In this role, he oversees clinical initiatives and product development strategies, focusing on innovation in the biopharmaceutical field. His medical expertise is essential for the company's success.